Scribd Logo
Upload

Welcome to Scribd!

  • Template Umum

    Uploaded by

    safaridika
    4 views2 pages
    The document discusses treatment plans for two medical cases: 1. A new case of pulmonary TB. The plan is to perform diagnostic tests like sputum tests and chest x-rays. Based on test results, the patient will receive first-line or second-line drug therapy, with monitoring of vital signs and symptoms. 2. A case of homogeneous opacity in the right lung. The plan is to conduct tumor marker tests, CT scans, bronchoscopy, and biopsy to determine if it is adenocarcinoma, squamous cell carcinoma, or small cell lung cancer. Based on tumor type and biomarkers, treatment may include targeted drugs, chemotherapy, radiotherapy, or tumor resection, with monitoring during treatment.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document discusses treatment plans for two medical cases: 1. A new case of pulmonary TB. The plan is to perform diagnostic tests like sputum tests and chest x-rays. Based on test results, the patient will receive first-line or second-line drug therapy, with monitoring of vital signs and symptoms. 2. A case of homogeneous opacity in the right lung. The plan is to conduct tumor marker tests, CT scans, bronchoscopy, and biopsy to determine if it is adenocarcinoma, squamous cell carcinoma, or small cell lung cancer. Based on tumor type and biomarkers, treatment may include targeted drugs, chemotherapy, radiotherapy, or tumor resection, with monitoring during treatment.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    4 views2 pages

    Template Umum

    Uploaded by

    safaridika
    The document discusses treatment plans for two medical cases: 1. A new case of pulmonary TB. The plan is to perform diagnostic tests like sputum tests and chest x-rays. Based on test results, the patient will receive first-line or second-line drug therapy, with monitoring of vital signs and symptoms. 2. A case of homogeneous opacity in the right lung. The plan is to conduct tumor marker tests, CT scans, bronchoscopy, and biopsy to determine if it is adenocarcinoma, squamous cell carcinoma, or small cell lung cancer. Based on tumor type and biomarkers, treatment may include targeted drugs, chemotherapy, radiotherapy, or tumor resection, with monitoring during treatment.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    of 2

    Analisis dan Rencana Awal

    No Masalah Rencana Diagnosis Rencana Terapi Monitoring

    4. TB Paru kasus baru Cek SITB untuk hasil Berdasarkan hasil GeneXpert: VS, CS
    TCM sputum · jika Genexpert MTB (+) ESO OAT
    KS sputum MTB rifampisin sensitive : OAT lini 1
    (BW 45 kg)
    R450/H200/Z1000/E750
    · jika Genexpert MTB (+)
    rifampisin resistance, check LPA
    second line :
    · If eligible, FQ sensitive: 6
    month regimen BPaLM
    · If eligible FQ resistance : 6-9
    regimen BPaL
    If not eligible BPaLM dan
    eligible STR, beri STR: 4-6 Bdq-
    Lfx-Cfz-HDT-Z-E-Eto / 5 Lfx-
    Cfz-Z-E
    If not eligible, regimen individu :
    3 drugs Group A (Bdq – Lfx –
    Lnz) + 2 drugs Group B (Cfz –
    Cs) + add on Group C (E)
    If GeneXpert MTB (-) : ATD
    based on clinical
    Analisis dan Rencana Awal
    No Masalah Rencana Diagnosis Rencana Terapi Monitoring

    4. Opasitas homogen
    Dextra
    assessment:
    1. Tumor paru - Tumor marker (CEA, Cyfra21-1, - Jika Adenocarcinoma EGFR mutasi • VS, Cs
    NSE) (+) -> TKI • ES Kemoterapi
    - CT-scan Thorax dengan kontras - Jika Adenocarcinoma EGFR mutasi
    - Bronkoskopi (-) -> cek ALK dan PDL-1
    - Core biopsy dengan USG/CT- Jika ALK (+) -> Crizotinib, Alectinib
    guiding Jika ALK (-), PDL-1 >50% ->
    Kemoterapi platinum based +
    Imunoterapi (opsional)
    Jika ALK (-), PDL-1 > 1-49% ->
    Kemoterapi platinum based
    - Jika squamous cell Carcinoma ->
    Kemoterapi platinum based
    - Jika small cell carcinoma ->
    Kemoterapi platinum based

    2. Tumor - Tumor marker (LDH, B HCG, AFP) - Kemoterapi, radioterapi, reseksi • VS, Cs
    mediastinum - CT-scan Thorax dengan kontras tumor tergantung staging dan • ES Kemoterapi
    - Core biopsy histo PA

    You might also like